DXCM vs PLUS · P/E 63, rev $4.03B vs P/E 17, rev $2.07B
DexCom Inc (DXCM) versus ePlus inc (PLUS) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
ePlus inc (PLUS) is a software - application company listed on NASDAQ.
Latest reported DXCM revenue for 2024-12-31 was $4.03B. Net income was $576.2M. Revenue was up 11.3% from 2023-12-31 to 2024-12-31. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported PLUS revenue for 2025-03-31 was $2.07B. Net income was $108.0M. Revenue was down 7.0% from 2024-03-31 to 2025-03-31. PLUS currently screens at market cap $2.10B and trailing P/E 17.1.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. PLUS currently screens at market cap $2.10B and trailing P/E 17.1.
Not investment advice. Open the DXCM and PLUS stock pages for the full models.
Not investment advice.